SCHEMBL11287159

SCHEMBL11287159

CCn1c(C)c(C)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.59
ALDH1A1 P00352 7/20 0.57
HSD17B10 Q99714 4/20 0.53
MAPT P10636 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
HTT P42858 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
NSD2 O96028 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
GRIK2 Q13002 1/20 0.53
LMNA P02545 1/20 0.49
ALOX15 P16050 1/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.49
HBB P68871 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10053035 0.84 KDM4E (0.65) KDM4EALDH1A1HSD17B10MAPTMEN1
Iodide SCHEMBL31343169 0.82 KDM4E (0.63) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL3972797 0.82 ALDH1A1 (0.60) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL3972794 0.82 ALDH1A1 (0.60) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL11681291 0.80 ALDH1A1 (0.53) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL13877259 0.80 ALDH1A1 (0.53) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL151563 0.80 ALDH1A1 (0.75) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL29360167 0.80 ALDH1A1 (0.75) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL29963695 0.80 ALDH1A1 (0.75) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL6013329 0.80 KDM4E (0.59) KDM4EALDH1A1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1051668-A Contain the dyeing composition for keratinous fibres of oxidation colorant parent and 4-hydroxy indoxyl derivative colour former and use the staining that said composition is carried out OREAL (FR) 1991-05-29 CN claimed
EP-2484526-B1 INKJET RECORDING METHOD AND PRINTED MATERIAL FUJIFILM CORP (JP) 2017-03-22 EP disclosed
US-9523031-B2 Organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2016-12-20 US disclosed
US-20160263234-A1 PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS ONYX THERAPEUTICS, INC. 2016-09-15 US disclosed
US-9315542-B2 Prodrugs of peptide epoxy ketone protease inhibitors ONYX THERAPEUTICS, INC. (US) 2016-04-19 US disclosed
US-9309283-B2 Prodrugs of peptide epoxy ketone protease inhibitors ONYX THERAPEUTICS, INC. (US) 2016-04-12 US disclosed
US-20140105921-A1 Prodrugs of Peptide Epoxy Ketone Protease Inhibitors ONYX THERAPEUTICS, INC. 2014-04-17 US disclosed
US-20070224448-A1 Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD. (JP) 2007-09-27 US disclosed
US-20070224448-A1 Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD. (JP) 2007-09-27 US disclosed
US-20070190355-A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same IDEMITSU KOSAN CO., LTD (JP) 2007-08-16 US disclosed
US-20070190355-A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same IDEMITSU KOSAN CO., LTD (JP) 2007-08-16 US disclosed
US-20070072911-A1 Indoles and azaindoles as antiviral agents AVOLIO SALVATORE 2007-03-29 US disclosed
US-20070009760-A1 Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device INOUE TETSUYA 2007-01-11 US disclosed
US-20070009760-A1 Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device INOUE TETSUYA 2007-01-11 US disclosed
CN-1051668-A Contain the dyeing composition for keratinous fibres of oxidation colorant parent and 4-hydroxy indoxyl derivative colour former and use the staining that said composition is carried out OREAL (FR) 1991-05-29 CN disclosed
US-4315068-A CONTAINING A COBALT-AMMINE COMPLEX AND A DIOXIME OR A BISIMIDAZOLIN-3-ONE CHELATING AGENT; STABILITY; COLOR DILMS RICOH CO., LTD. (JP) 1982-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140105921-A1 Prodrugs of Peptide Epoxy Ketone Protease Inhibitors PREP, VIP, PEPD KDM4E 377/4885ALDH1A1 1285/4885HSD17B10 493/4885
US-20160263234-A1 PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS PREP, VIP, PEPD KDM4E 377/4885ALDH1A1 1285/4885HSD17B10 493/4885
US-20070072911-A1 Indoles and azaindoles as antiviral agents IDO1, IDO2, NAT1 KDM4E 1002/4885ALDH1A1 453/4885HSD17B10 2995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.